Austrian pharma company alleges arbitral fraud
Bad blood: the pharma companies have brought actions against each other in Germany and the US (Credit: Shutterstock/Ekaterina 1525)
An Austrian pharmaceuticals company has asked a US court to grant discovery to support criminal allegations that its Taiwanese partner has made fraudulent statements in two ICC arbitrations arising from a multibillion-euro dispute over a blood cancer drug.
To read more
Subscribe to Global Arbitration Review
Subscribe and start reading now
Global Arbitration Review (GAR) is the online home for international arbitration specialists, telling them everything they need to know about all the developments that matter.
Subscribe now